Ben A. C. Dijkmans

37.0k total citations · 7 hit papers
332 papers, 25.0k citations indexed

About

Ben A. C. Dijkmans is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Ben A. C. Dijkmans has authored 332 papers receiving a total of 25.0k indexed citations (citations by other indexed papers that have themselves been cited), including 231 papers in Rheumatology, 60 papers in Hematology and 53 papers in Immunology. Recurrent topics in Ben A. C. Dijkmans's work include Rheumatoid Arthritis Research and Therapies (190 papers), Systemic Lupus Erythematosus Research (103 papers) and Spondyloarthritis Studies and Treatments (57 papers). Ben A. C. Dijkmans is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (190 papers), Systemic Lupus Erythematosus Research (103 papers) and Spondyloarthritis Studies and Treatments (57 papers). Ben A. C. Dijkmans collaborates with scholars based in Netherlands, United States and Germany. Ben A. C. Dijkmans's co-authors include Michael T. Nurmohamed, Alexandre E. Voskuyl, Willem F. Lems, Dirkjan van Schaardenburg, Maarten Boers, Désirée van der Heijde, Cornelia F Allaart, Margret H. M. T. De Koning, Jan P. Vandenbroucke and Sjef van der Linden and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Ben A. C. Dijkmans

328 papers receiving 24.0k citations

Hit Papers

The European Spondylarthropathy Study Group Preliminary C... 1991 2026 2002 2014 1991 2004 2005 1997 2006 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The European Spondylarthropathy Study Group Preliminary Criteria for the Classification of Spondylarthropathy
    1991 1.7k citations Sjef van der Linden, A. Cats et al. Arthritis & Rheumatism profile →
  2. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors
    2004 1.4k citations Jan P. Vandenbroucke, Ben A. C. Dijkmans et al. Arthritis & Rheumatism profile →
  3. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial
    2005 1.1k citations Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. Arthritis & Rheumatism profile →
  4. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    1997 800 citations Maarten Boers, J. Christiaan van Denderen et al. profile →
  5. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
    2006 660 citations Désirée van der Heijde, Joachim Sieper et al. Arthritis & Rheumatism profile →
  6. Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
    2005 651 citations Désirée van der Heijde, Ben A. C. Dijkmans et al. Arthritis & Rheumatism profile →
  7. Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
    2007 448 citations Carla A. Wijbrandts, Michael T. Nurmohamed et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben A. C. Dijkmans Netherlands 83 18.3k 6.3k 6.1k 2.8k 2.4k 332 25.0k
Steven M. Edworthy Canada 30 15.9k 0.9× 4.4k 0.7× 3.7k 0.6× 2.4k 0.8× 2.6k 1.1× 51 24.6k
Michael H. Weisman United States 67 14.9k 0.8× 6.2k 1.0× 5.0k 0.8× 2.2k 0.8× 2.4k 1.0× 340 22.2k
Ferdinand C. Breedveld Netherlands 67 15.2k 0.8× 5.4k 0.9× 5.4k 0.9× 2.3k 0.8× 3.4k 1.4× 182 21.9k
Harvinder S. Luthra United States 34 13.7k 0.8× 4.8k 0.8× 3.6k 0.6× 2.2k 0.8× 3.2k 1.4× 96 20.4k
Maxime Dougados France 83 18.9k 1.0× 6.4k 1.0× 5.4k 0.9× 1.6k 0.6× 1.6k 0.7× 395 24.8k
Vibeke Strand United States 73 15.4k 0.8× 6.3k 1.0× 5.6k 0.9× 1.5k 0.5× 2.2k 0.9× 522 22.9k
Larry W. Moreland United States 59 12.2k 0.7× 4.7k 0.8× 5.0k 0.8× 1.8k 0.6× 2.3k 1.0× 291 18.9k
Josef S Smolen Austria 69 12.5k 0.7× 5.5k 0.9× 3.8k 0.6× 4.8k 1.7× 1.8k 0.7× 342 20.7k
Stanley Cohen United States 61 10.5k 0.6× 4.5k 0.7× 4.7k 0.8× 3.2k 1.1× 1.7k 0.7× 214 18.4k
Daniel Aletaha Austria 64 15.0k 0.8× 4.7k 0.7× 5.4k 0.9× 2.9k 1.0× 1.5k 0.6× 327 21.2k

Countries citing papers authored by Ben A. C. Dijkmans

Since Specialization
Citations

This map shows the geographic impact of Ben A. C. Dijkmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben A. C. Dijkmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben A. C. Dijkmans more than expected).

Fields of papers citing papers by Ben A. C. Dijkmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben A. C. Dijkmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben A. C. Dijkmans. The network helps show where Ben A. C. Dijkmans may publish in the future.

Co-authorship network of co-authors of Ben A. C. Dijkmans

This figure shows the co-authorship network connecting the top 25 collaborators of Ben A. C. Dijkmans. A scholar is included among the top collaborators of Ben A. C. Dijkmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben A. C. Dijkmans. Ben A. C. Dijkmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansen, Gerrit, Karin Weijers, Yoony Y. J. Gent, et al.. (2013). Folates and antifolates in rheumatoid arthritis. Pteridines. 24(1). 21–26. 1 indexed citations
2.
Verbrugge, Sue Ellen, Diba Emal, Sinéad M. Lougheed, et al.. (2012). Targeting the immunoproteasome with the second generation proteasome inhibitor ONX 0914: effects on IFN-alpha-induced monocyte-derived dendritic cells (119.4). The Journal of Immunology. 188(1_Supplement). 119.4–119.4. 2 indexed citations
3.
Broek, Maries van den, Naomi B. Klarenbeek, Linda Dirven, et al.. (2011). Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the Rheumatic Diseases. 70(8). 1389–1394. 98 indexed citations
4.
Horst‐Bruinsma, Irene E. van der, J. Christiaan van Denderen, I.M. Visman, et al.. (2010). Decreased Recurrence Rate of Anterior Uveitis in Ankylosing Spondylitis Treated with Adalimumab - An Interim Analysis. Clinical and Experimental Rheumatology. 28(4). 630–630. 8 indexed citations
5.
Heijden, Joost W van der, Ruud Oerlemans, Paul P. Tak, et al.. (2009). Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis & Rheumatism. 60(3). 669–677. 54 indexed citations
6.
Dijkmans, Ben A. C., Paul Emery, Markku Hakala, et al.. (2009). Etanercept in the Longterm Treatment of Patients With Ankylosing Spondylitis. The Journal of Rheumatology. 36(6). 1256–1264. 51 indexed citations
7.
Baarsen, Lisa G. M. van, Carla A. Wijbrandts, François Rustenburg, et al.. (2008). IFN/TNF cross-regulation in vivo during infliximab treatment in rheumatoid arthritis. Arthritis & Rheumatism. 58(9). 1 indexed citations
8.
Peters, Mike J., Vokko P. van Halm, Alexandre E. Voskuyl, et al.. (2008). Rheumatoid arthritis as important independent risk factor for incident cardiovascular disease. Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam). 58(9). 2 indexed citations
9.
Halm, Vokko P. van, Matthew Peters, Alexandre E. Voskuyl, et al.. (2008). Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRÉ Investigation. Annals of the Rheumatic Diseases. 68(9). 1395–1400. 270 indexed citations
10.
Heijde, Désirée van der, Ben A. C. Dijkmans, A. Kivitz, et al.. (2008). Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS). Oxford University Research Archive (ORA) (University of Oxford). 58. 2 indexed citations
11.
Kraan, Tineke C. T. M. van der Pouw, Carla A. Wijbrandts, Lisa G. M. van Baarsen, et al.. (2007). Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients. Annals of the Rheumatic Diseases. 66(8). 1008–1014. 234 indexed citations
12.
Jacobs, Johannes W G, R. N. J. de Nijs, Willem F. Lems, et al.. (2007). Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.. University of Groningen research database (University of Groningen / Centre for Information Technology). 34(5). 1051–7. 25 indexed citations
13.
Kooij, S M van der, Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, et al.. (2007). Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Annals of the Rheumatic Diseases. 66(10). 1356–1362. 71 indexed citations
14.
Oerlemans, Ruud, Ben A. C. Dijkmans, Gertjan J.L. Kaspers, et al.. (2006). Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance–associated protein 1 and provokes high levels of cross‐resistance to glucocorticoids. Arthritis & Rheumatism. 54(2). 557–568. 31 indexed citations
15.
Nijs, R. N. J. de, Johannes W. G. Jacobs, Willem F. Lems, et al.. (2006). Alendronate or Alfacalcidol in Glucocorticoid-Induced Osteoporosis. Obstetrical & Gynecological Survey. 62(1). 37–38. 28 indexed citations
16.
Croon, E. M. de, et al.. (2004). Predictive factors of work disability in rheumatoid arthritis: a systematic literature review. Annals of the Rheumatic Diseases. 63(11). 1362–1367. 184 indexed citations
17.
Kraan, Maarten C., et al.. (2004). Differential effects of leflunomide and methotrexate on cytokine production in rheumatoid arthritis. Annals of the Rheumatic Diseases. 63(9). 1056–1061. 44 indexed citations
18.
Meuwissen, S. G. M., Bart J. A. Crusius, Salvador A. Peña, A. J. Dekker-Saeys, & Ben A. C. Dijkmans. (1997). Spondyloarthropathy and Idiopathic Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 3(1). 25–37. 4 indexed citations
19.
Janssen, M., Ben A. C. Dijkmans, Jan P. Vandenbroucke, et al.. (1995). Serum Values of Pepsinogens and Antibodies to Helicobacter Pylori in Relation to a History of Peptic Ulcer Disease and NSAID Use. Scandinavian Journal of Rheumatology. 24(4). 204–208. 3 indexed citations
20.
Dijkmans, Ben A. C., et al.. (1989). Penetration of cyclosporin into synovial fluid in rheumatoid arthritis. European Journal of Clinical Pharmacology. 37(3). 321–322. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven M. Edworthy Breakdown of academic impact, for papers by Michael H. Weisman Breakdown of academic impact, for papers by Ferdinand C. Breedveld Breakdown of academic impact, for papers by Harvinder S. Luthra Breakdown of academic impact, for papers by Maxime Dougados Breakdown of academic impact, for papers by Vibeke Strand Breakdown of academic impact, for papers by Larry W. Moreland Breakdown of academic impact, for papers by Josef S Smolen Breakdown of academic impact, for papers by Stanley Cohen Breakdown of academic impact, for papers by Daniel Aletaha
Rankless by CCL
2026